for Alright. afternoon. joining us Thanks, thanks And Joel. everyone this
We against results call strategic our will health here health of with including long-term be intelligence an today growing goals. third progress financial over start to and product Isaac and for new update. before to are our to the with operating quarter platform, our today's our our I I discuss growth, pleased call you pass a information system partnerships, overview offerings, and results
in open our I'm will very our questions. the for investment which in foundation of by call Overall, organizational We quarter, organization. then was excited facets all a of operational our across for progress the largely growth third quarter
see notable you have quarter, to volumes our engagement a can platform, with see accelerating X in of exiting the started As investments our to patient momentum we and progress acceleration into translate as presentation, we from XXXX. earnings Slide these provider our and
insights deliver clinical anchored that spectrum fundamentally physicians, for on infrastructure, public investment and became their active other records data in We roadmap combined SemaX and multi-omic collaboration of outcomes can analyses health clinical decisions to patient clinical believe partners patients a building Since people. July, longitudinal help data, inform drive and best high data differentiated dimension and patients. help large-scale and with broad lifestyle engagement decision-making across that we up genomic and and clinical ensure in that patients. patient insights with research our ramped the with delivering Company The technology, are clinical will on diseases individual based we actionable unique for We focused our strategic in data have a a clinically Company is and conditions.
or the among our 's the XX SemaX access third is existence. XX health million high-quality, Our capacity quarter, health platform electronic Meanwhile, by us data longitudinal and of in to largest, was end from high-dimensional petabytes to growing most fastest to platform of XX continues and our give proprietary At comprehensive, expansive data, million roughly information. these patients. by underpinned and to patients, platform gigabyte health managing medical the record access million our partners. information Centrellis, success approximately data support our gathered XX testing integrated system intelligence platforms run our Of
data can set for now XX% coming capacity year. our of current support Next-Gen more Sequencing in Our than growth the genomic
continue in we the relevant infrastructure addition, insights to to from clinically invest derive required In data. the
resonating We is in build of a the continue our platform believe to strategy marketplace. algorithms to that
competitive It relationships unrivaled sets access knowledge that and and providers, SemaX. to patient-informed to genomic records, consent engaged that the and continue have within of long-term us a large-scale partners any outcomes acquire very continuously partnership In manage than to The the level and other drive with As access information health information this engage encouraging. the allow this with health to knowledge deep This and will advanced with partners. is feedback data remains patient differentiator majority of with cases, information an all leverage is SemaX for develop health and data. and of understanding ever testing and to importantly, data, personal It high pharmaceutical health patient medical drive greater provides with longitudinal patient. SemaX business systems hospital portal, is and believe physician our we health records, results, consenting system our SemaX platform. many to partnership help patients to and population their patients to very of improve all example, allow information-based improved and XX% we those proposition us electronic includes Most generated of the all. value record for for that patients notes, patients, medical to
system breadth the increasingly becomes scale attractive. health and our to value our advances, proposition of As data also
During the fourth quarter, system Health. Avera third health a we added partnership
a is 's of program clinicians system data-driven provide let we health Chicagoland a treat our area health system-wide, many overview greater diverse tremendous and Earlier earlier care. X medicine with we're launched where we stages. large to-date. getting success deliver the our culturally their system me NorthShore in at NorthShore example In to prevent, of partners, an an of medicine detect, in platform have this just leveraged underserved increasingly had As partnership. NorthShore diseases the and traction to year, communities, precision has an and patients, months, standard NorthShore patients genomic help our improved
comprehensive a Earnings and XX% select were process, months patients As complete the our which cancer, Presentation, first conditions. of cancer have and Roughly to and as XX% risk nearly medical at for family XXXX history questionnaire, from increase being our have remarkable patient the can guidelines patients represents genomic same test before wellness ordered. standard Slide and our NCCN system. of A with XX,XXX tested. XX% XXXX. significantly X-month and patients assessment take after care NorthShore this health From over this the general screening our meeting or and care X have we been the test. quickly hereditary XX,XXX improve an covering increase screen genomic through with a through believe have completed summarized summary, NorthShore the and at identified X,XXX of X the a In platform This evidence in of prior heritable and had increase genomic And guideline-based advised in success physicians test go-to-market in than NorthShore period a group, launch, a starts care. genetic primary period had NorthShore more more high launch, improvement the successfully of strategy testing whether personal questionnaire early the that versus of X-month in standard is health
to pilot partnership significant the achieved then with at heritable for primary these through families a standard an starting of success in at cancer Thus, to we testing than X August a retailer encouraging of SemaX to take process returning their extended NorthShore enhanced in cancer performed women mammography located samples facilities an in care. was 's having and quickly assessment to of We're placed greatly The cancer generally females the to this are mammography NorthShore following their the facility increase positive 's program, additional patients affected all of and heritable facilities, NorthShore heritable concept exemplified of the program detection, saliva scheduled SemaX treatment genetic and testing. and XX% testing support the counseling on help sample growing The has screenings, mammography Skokie, the Earlier of receiving cancer with innovative results a expanding very can all heritable the other clothing deep levels and in by with is are and when compared NorthShore that us Centrellis Illinois. partnership care, innovative introduction testing far the orders enabled setting. in program an have patients The mammography with Nordstrom program communities. provide in their network. Our for exceed have approach NorthShore medical evidence-based clinic. Both screening cancer This risk, partners. the engine, so impact is the differential has pilot of encouraged also care substantial of targeted survival. by and guidelines. seen screening providing annual The non-traditional beyond pilot with screening more
in ultimately molecular to be combined improved on data are well profile greater profiles rest types Integrating data has medical Genomic in It organizations somatic clinical as to the record deep Lastly, patients partnerships, electronic months X which NorthShore. system access that care. of a curation medical and many all for we record our collected NorthShore, both s the the All-in-all, believe by project partners the as sequenced and We embarking span time, treatment of called we part SemaX. samples data The Avera in through partners. of levels dedication protocol as the a our span and of provide with with pair than the and more these expansive profiling will SemaX separate leading geography system are for mutually at these our longitudinal Health structuring several genomic -- launching process adoption XXXX include data more growing the longitudinal from the Avera beneficial research on a Health Avera as now health to with guidance. tumor with standard patients than electronic Initiative, of with engagements is of of at to system the pleased actionable cancer already personalized profiling is
expand focus existing solutions partnerships on developed limited As new patient scaling partners, with system with health to to strategy. to traction we a establish continue new partnerships learning-based longer-term, our the and we of base partnership. will first Then types of gain system health look engagement the clinician number learning
of driving feature number a distinguishing takes Although systems systems will ourselves choice to to state-of-the-art integrating relationships, we partner time believe our ultimately care care. it the these preferred precision of collaborative s who as increasing us are an as provide as within develop standard medicine the of partner health that of to position
to advantages evident studies. to In unique to the progressive our addition sources to many pharmaceutical companies more data leverage draws sophisticated from provide drug clinical support big Health trials insights platform upon development research to that real-world Systems, from information looking in
a level engagement the pharmaceutical of have surveillance. span with spectrum We growing post-marketing to drug companies of discovery that
right right grow System innovators We time. of efficiency look therapeutics and the they our drug as to at development, to the the pharmaceutical with improve expect contributions the accuracy significantly we to to in to partners, Similar pharma the seek right and delivery XXXX. partner patient of Health
in the of informed SemaX we partners. to Our data to insights what to help what is goal and decisions. from to them understand the pharmaceutical believe patients our clinically needs can biopharma order to hospital data better The partner bring a accurate highly make is and connectivity systems provide actionable
the for we On and management diligently diagnosis, reproductive generational the enhanced enable patients portfolio This portfolio reproductive tools their These [Indiscernible] more cancer and are holistic providers, planning, holistically risk products to sophisticated Elements. allowed types IVF treatment, it share specific groups, to To The market, data-science of and September, testing, treat is and our services, version cancer pregnancy to generational [Indiscernible] know Alongside for provide in are driven front, to market broaden comprised prescribing that science-driven derived new component screening the a accurately offering. our market ancestry for and heritable IVF of has product family includes ECS concentrated is encompasses population testing assess conditions Natalis journey. services is non-invasive genomic more we the solutions at level, key version of you well, a product and reproductive prenatal which providers newborn and and patients prediction. our expanded 's disease the inheritable those SemaX us prevention, Health. risk the to who SemaX from screening, high highly For resonating include even upgraded physicians. In and for during don't of care. molecular support of health working to specific accounts. take proud We're digital of superior carrier launched national newly solutions,
cycle related medical these first are s Postpartum digitally and associated papers in our factors accounting known call model of into assessment. were pregnant standard of with By utility The we're health of real-world accurately accurately hemorrhage our support globally care, includes our more X of issue pair of high platform second our studies the third and XX% volumes growing with of adequately the system improve database, quarter. studies in our we for for the productivity our women. longer-term marched health are Informatics [Indiscernible] ordering the for pregnant the and results this standard patients large-scale, Mount comprehensive as These productivity. postpartum data System, to accounts adoption toward vision back and clinically reps Health to our over are care X,XXX growth third insights their a in growth beginning Shifting staffed we this quarter. in thus in of we commercial management be platform risk death, health of both To we American the the XX% I'd are -XX ramping expanded see roughly postpartum full due the headcount predictive for in partner, the improving featured of and implementing and may have highlighted in under-served mission of mortality not new Society. of objectives, in as seeing providers no of to the care our these We intelligence phenotype current among communities. use hemorrhage to health to our the conducted the wins accounts began Sinai as immune new of risk sex we deck. fourth-quarter through for maternal outcomes to and health Health are to end not since monetizing journal meaningful health partnerships resulting and collaboration demonstrating informatics better mortality outcomes. then part to sales founding out assessment to by third force timing, the occurs predict earnings sales developing a quarter, a While employees clinical with of XX% increased of algorithms. special U.S. our to the believe improvements and rate, is during of case, hemorrhage. able This like quarter cause prediction the leading System trends far, were the encouraged clinically as our predict gender and the In meaningful often of published third patients patients highlight of for Medical quarter, and maternal outcomes. especially hemorrhage risk in
and hires improving are profile. efficiency lab, we of our operating overall and margin have working the made number key to a Turning toward
fastest-growing through a normalized limbs oncology, help outlined us XXXX. automation as we segment, initiatives These pace have in an portfolio with for optimization, reimbursement We more including dynamic combined margins pace number internal improving will new and initiatives. implementation, initiatives of our
Gustavo algorithms of we key information the Chief His help patients Stolovitzky Officer. hired providers, actionable as and into a systems, health in computational accelerating data of in to renowned platform health the expert knowledge. biology, is development Scientific our expertise Additionally, in contained Dr. world September, researchers, translate to
with our other Health core the we our biopharmaceutical lead also progress collaborative have business intelligence health world platform. for setting summary, We is in capabilities, the future research In value software, made partnerships substantial artificial our building bar the into further of platforms solidify Coupled our and product, we proprietary as translation most and grow objectives SemaX learning Systems industry. the on in and top-notch high intelligence of one machine-learning, patient engagement. sophisticated advanced with our team the
incredibly be ability in that to differentiated the to for our standard continue confident in drive We -time of real dramatically care improve insights can all.
SemaX explore As opportunities for financials remains of and our we over up scale actively the growth, turn bright. Isaac and now very strategic And the I future investments, it to activities, will guidance. collaborations, for inorganic commercial
